Page 43 - RPIA_25-2

ANGIOEDEMA INDUZIDO POR INIBIDORES DA ENZIMA
DE CONVERSÃO DA ANGIOTENSINA / CASO CLÍNICO

6. Williams -Herman D, Round E, Swern AS, Musser B, Davies MJ, Stein Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicar-
9.
PP, et al Safety and tolerability of sitagliptin in patients with type 2 di M. Long term follow up of 111 patients with ACE induced an-
diabetes: A pooled analysis. BMC Endocr Disord 2008; 8: 14. gioedema. J Hipertens 2011; 29: 2273 -7.
Toh S, Reichman ME, Houston M, Ross Southworth M, Ding X, 10. Haymore BR, Yoon J, Mikita CP, Klote MM, DeZee KJ. Risk of
7.
Hernandes AF, et al. Comparative risk for angioedema associated angioedema with angiotensin receptor blockers in patients with
with the use of drugs that target the rennin -angiotensin- prior angioedema associated with angiotensin -converting enzyme
-aldosterone system. Arch Intern Med 2012; 172: 1582 -9. inhibitors: a meta -analysis Ann Allergy Asthma Immunol 2008;
8. Beltrami L, Zingale LC, Carugo S, Cicardi M. Angiotensin- 101: 495 -9.

-converting enzyme inhibitor -related angioedema: how to deal
with it. Expert Opin Drug Saf 2006; 5:643 -9.

131

REVIST A POR TUGUESA DE IMUNO ALERGOLOGIA